Observational studyMedicine2026
Mortality trends involving fatal-arrhythmias and anemia in the United States: A retrospective analysis of 25 years.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to examine long-term trends in age-adjusted mortality rate associated with cardiac arrhythmias among anemic adults in the United States from 1999 to 2023 and assess disparities by sex, race/ethnicity, geographic region, and urban-rural residence. For this retrospective observational study, the data was extracted from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research. International classification of disease (ICD)-10 codes were used to identify cardiac arrhythmia and anemia. We used Joinpoint Regression Program (V.5.4.0) for the analysis of trends and a P-value of <.05 was considered statistically significant. The overall age-adjusted mortality rate for cardiac arrhythmia in anemic patients increased from 2.30 in 1999 to 5.03 in 2023, showing a more than 2-fold rise over the 25-year period. Males consistently had a higher mortality than females, rising from 2.64 to 6.11 in men and from 2.09 to 4.28 in women between 1999 and 2023. Non-Hispanic (NH) White adults had the highest mortality, followed by NH Blacks or African American, Hispanics, and NH others respectively throughout 1999 to 2023. Highest mortality rates were observed in Rhode Island, West Virginia, Ohio, and Vermont. Rural areas had higher mortality than urban areas, rising from 2.52 to 5.63 compared with 2.24 to 4.14 in urban areas between 1999 and 2020. The highest mortality rates were in the midwest and south. In conclusion, mortality from cardiac arrhythmias in anemic adults has increased significantly over the past 25 years. There are disparities by sex, race, region, and rural versus urban setting that suggest the need for focused interventions and targeted policy design for vulnerable communities to avoid preventable deaths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.